Clinical Trial

Descartes-08 for Patients With Systemic Lupus Erythematosus

Study acronym: SLE-001
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a Phase II study to evaluate the safety, tolerability and manufacturing feasibility of Descartes-08 CAR T-cells in patients with Systematic Lupus erythematosus (SLE).
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-09-08; most recent amendment 2026-03-23.
Status change: Recruiting → Active, Not Recruiting 2025-11-19
Status change: Not Yet Recruiting → Recruiting 2024-02-27
Trial Details
NCT Number NCT06038474
Lead Sponsor Cartesian Therapeutics
Conditions Systemic Lupus Erythematosus (SLE)
Enrollment 6 participants
Start Date 2024-02-12
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-27